COVID-19 Alert
For the latest updates from UVM Health Network on COVID-19, click here
The UVM Cancer Center has adjusted some of the ways we provide care and support to protect our patients and staff and ensure safe social distancing. Read important details here.
The National Cancer Institute has a COVID-19 resource page for cancer patients that is helpful as additional information.

HeimannCT
InfusionBay
KragwPatient

Patient Care & Clinical Services

The University of Vermont Cancer Center is working to translate the latest research findings into life-saving care options that make a difference in the lives of patients. More than 200 researchers and clinician-scientists across the University of Vermont and University of Vermont Medical Center are working together daily to the advance the prevention, detection, treatment and survivorship of cancer.

The UVM Cancer Center provides clinical care at the University of Vermont Medical Center where a personal and collaborative approach brings together all of the experts involved in a patient's care in one place, on the same day. This makes for a comprehensive approach to patient care, and makes better use of patients' time - reducing the number of appointments with various specialists. The team provides an evaluation and develops a personalized treatment plan that includes all the resources needed - education, diagnosis, treatment, research, and support. The UVM Cancer Center is one of less than 100 academic cancer centers nationally bringing cutting-edge cancer care to their communities and advancing cancer research globally.

Visit Cancer Care at The University of Vermont Medical Center for more information about clinical services and cancer care at the UVM Cancer Center.

In light of all in-person support groups being on hold, the Frymoyer Resource Center at the UVM Medical Center has put together a reputable list of online or remote support resources that cancer patients and their loved ones can access.

To view the Support Groups list, click here for a printable PDF.